Related references
Note: Only part of the references are listed.Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy
Keziah Cook et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin
Marissa Lightbourne et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
Yusei Hosokawa et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
Role of Leptin in Cardiovascular Diseases
Mareike S. Poetsch et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Leptin decreases de novo lipogenesis in patients with lipodystrophy
Annah P. Baykal et al.
JCI INSIGHT (2020)
Amélioration des triglycérides et du HDL-cholestérol sous métréleptine dans les syndromes lipodystrophiques avec syndrome metabolique modeste
L. Leguier et al.
ANNALES D ENDOCRINOLOGIE (2020)
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles
Takahiro Fukaishi et al.
ENDOCRINE JOURNAL (2020)
Diagnosis and treatment of lipodystrophy: a step-by-step approach
D. Araujo-Vilar et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants
Hilal Sekizkardes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Effects of Metreleptin on Proteinuria in Patients With Lipodystrophy
Ho Lim Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Adherencewith metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
Camille Vatier et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
An overview of lipodystrophy and the role of the complement system
F. Corvillo et al.
MOLECULAR IMMUNOLOGY (2019)
Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment
Janett Pueschel et al.
CYTOKINE (2019)
Cardiometabolic assessment of lamin A/C gene mutation carriers: A phenotype-genotype correlation
M. Kwapich et al.
DIABETES & METABOLISM (2019)
Starvation in the Midst of Plenty: Reflections on the History and Biology of Insulin and Leptin
Jeffrey S. Flier
ENDOCRINE REVIEWS (2019)
Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn's disease
Joern F. Ziegler et al.
NATURE COMMUNICATIONS (2019)
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
Elif A. Oral et al.
ENDOCRINE (2019)
Advanced Lipoprotein Analysis Shows Atherogenic Lipid Profile That Improves After Metreleptin in Patients with Lipodystrophy
Alexandra B. Kinzer et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Renal complications of lipodystrophy: A closer look at the natural history of kidney disease
Baris Akinci et al.
CLINICAL ENDOCRINOLOGY (2018)
Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy
Rebecca J. Brown et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy
Josivan Gomes Lima et al.
PLOS ONE (2018)
Lipodystrophic laminopathies: Diagnostic clues
Cristina Guillin-Amarelle et al.
NUCLEUS (2018)
Lipodystrophic laminopathies: Diagnostic clues
Cristina Guillin-Amarelle et al.
NUCLEUS (2018)
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
Rebecca J. Brown et al.
ENDOCRINE (2018)
Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review
Nidhi Gupta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy
Ranganath Muniyappa et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Insulin secretory defect in familial partial lipodystrophy Type 2 and successful long-term treatment with a glucagon-like peptide 1 receptor agonist
F. Banning et al.
DIABETIC MEDICINE (2017)
One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes
C. Vatier et al.
DIABETES & METABOLISM (2017)
Lymphoma in acquired generalized lipodystrophy
Rebecca J. Brown et al.
LEUKEMIA & LYMPHOMA (2016)
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Jean L. Chan et al.
CLINICAL ENDOCRINOLOGY (2016)
Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior
Haiko Schloegl et al.
DIABETES (2016)
One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes
C. Vatier et al.
DIABETES OBESITY & METABOLISM (2016)
Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients
Amy E. Levenson et al.
ENDOCRINOLOGY (2016)
Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy
Andrea Kassai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Rebecca J. Brown et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program
Nevin Ajluni et al.
JOURNAL OF DIABETES & METABOLISM (2016)
Leptin Does Not Mediate Hypertension Associated With Human Obesity
Rebecca J. Brown et al.
CELL (2015)
A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin
Jasmin Lebastchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin
Talia Diker-Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
Hyeong-Kyu Park et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Identification and Saturable Nature of Signaling Pathways Induced by Metreleptin in Humans: Comparative Evaluation of In Vivo, Ex Vivo, and In Vitro Administration
Hyun-Seuk Moon et al.
DIABETES (2015)
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience
David Araujo-Vilar et al.
ENDOCRINE (2015)
Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin on metabolic and hepatic endpoints
Alexander J. Rodriguez et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2014)
Lipid Regulation in Lipodystrophy Versus the Obesity-Associated Metabolic Syndrome: The Dissociation of HDL-C and Triglycerides
Jalaja Joseph et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Leptin in common obesity and associated disorders of metabolism
Alex M. DePaoli
JOURNAL OF ENDOCRINOLOGY (2014)
The liver diseases of lipodystrophy: The long-term effect of leptin treatment
Elika Safar Zadeh et al.
JOURNAL OF HEPATOLOGY (2013)
How to diagnose a lipodystrophy syndrome
Marie-Christine Vantyghem et al.
ANNALES D ENDOCRINOLOGIE (2012)
Consequences of Stopping and Restarting Leptin in an Adolescent with Lipodystrophy
F. Kamran et al.
HORMONE RESEARCH IN PAEDIATRICS (2012)
Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety
Vinaya Simha et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Pregnancy in a Woman With Congenital Generalized Lipodystrophy
Marcy Maguire et al.
OBSTETRICS AND GYNECOLOGY (2012)
Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
Hyun-Seuk Moon et al.
DIABETES (2011)
CLINICAL EFFECTS OF LONG-TERM METRELEPTIN TREATMENT IN PATIENTS WITH LIPODYSTROPHY
Jean L. Chan et al.
ENDOCRINE PRACTICE (2011)
Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women
Elizabeth Sienkiewicz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin
Jacques Beltrand et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: The effect of long-term leptin therapy
Jean Y. Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy
Jean Y. Park et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy
Ken Ebihara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy
ED Javor et al.
HEPATOLOGY (2005)
Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess
JL Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients
C Musso et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy
SA Moran et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency
JR McDuffie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men
JL Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Clinical features and metabolic derangements in acquired generalized lipodystrophy - Case reports and review of the literature
A Misra et al.
MEDICINE (2003)
Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy
V Simha et al.
DIABETES CARE (2003)
Leptin-replacement therapy for lipodystrophy
EA Oral et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion
A Khan et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Leptin plasma concentrations are dependent on body fat distribution in obese patients
A Minocci et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
